Experimental and clinical evidence has established metabolic inflammation in adipose tissue—including cytokine signaling such as TNF-α and immune cell infiltration—as a key determinant of IR, β-cell dysfunction, and progression to type 2 diabetes (T2D) [1,2]. This evidence concerns the gene TNF and type 2 diabetes mellitus.